All filters
Slidesets
Use of Integrase Inhibitors in Latin America | Mônica Jacques de Moraes, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical case presentation | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Dual therapy regimens | Maria Ines Figueroa, MD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
HIV Integrase Inhibitors: A new mechanism of action | Charles Boucher, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Pharmacology and new modes of delivery | David Back, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Meeting
European HIV Clinical Forum 2018
Slidesets
Longer duration of virological suppression and a fully active companion drug ensure a high rate of virological control in HIV-1 infected patients switching to a dual therapy containing integrase inhibitors- Daniele Armenia
Presented at:
European HIV Clinical Forum 2018
Slidesets
Integrase inhibitors in specific populations- Women and those aging with HIV- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
European HIV Clinical Forum 2018
Slidesets
Long-acting ARV for treatment & prevention: clinical considerations- Laura Waters, MD, FRCP
Presented at:
European HIV Clinical Forum 2018
Slidesets
Pharmacologic characteristics and delivery options for integrase inhibitors- Courtney Fletcher, PharmD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Intergrase inhibitors- What's new?-Margaret Johnson, MD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Resistance to integrase inhibitors- What clinicians need to know- Roger Paredes, MD, PhD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Reduced drug regimens- What are the data?- Jose Arribas, MD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Switching antiretroviral therapy to safer strategies based on intergrase inhibitors- Pedro Cahn, MD, PhD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Heathy guts exclude oxygen- Andreas Bäumler, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018
Slidesets
Chemistry from the Microbiome and its role in health and disease- Robert Quinn, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018
Slidesets
Rapid gut epithelial repair at the enteroendocrine-immune intersection through microbiota-mediated rescue of tryptophan metabolism during chronic HIV/SIV infection- Clarissa Santos Rocha
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018
Slidesets
Monitoring and modifying the microbiome in the immunocompromised host- Ami Bhatt, MD, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018
Slidesets
The role of the intestinal microbiome in modulating HIV transmission risk- Ian McGowan, MB, ChB, DPhil, MD, FRC
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018
Slidesets
HIV COPD: Could differential host recognition of the lung microbiome be contributing to pulmonary disease?- Daniel Dunlap
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018
Slidesets
Gut microbiota, chronic inflammation and metabolic syndrome- Andrew Gewirtz, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018
Slidesets
Mucosal microbiomes with HIV infection and protection- Scott Handley, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018
Slidesets
A compositional transform reveals HIV exposure induced shifts in the fecal microbiota and vaccine responsiveness of Nigerian infants- Bryan Brown
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018